Skip to main content

and
  1. Article

    Open Access

    Effect of roxadustat on iron metabolism in patients with peritoneal dialysis: a real-world 24-week study

    Roxadustat is an oral hypoxia inducing factor-prolyl hydroxylase inhibitor (HIF-PHI) that regulates iron metabolism in patients with chronic kidney disease (CKD) primarily by reducing hepcidin levels and mobil...

    Xuejie Zhang, Ruoyu Jia, Zhifang Zheng, Luhua Jiang in European Journal of Medical Research (2023)